<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114423">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02054767</url>
  </required_header>
  <id_info>
    <org_study_id>FDAAA</org_study_id>
    <nct_id>NCT02054767</nct_id>
  </id_info>
  <brief_title>Anesthetic Efficacy in Irreversible Pulpitis</brief_title>
  <official_title>Anesthetic Efficacy of Articaine, Lidocaine and Mepivacaine in Patients With Irreversible Pulpitis of Mandibular Molar</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <authority>Brazil: National Committee of Ethics in Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to compare the anesthetic efficacy of articaine, lidocaine and
      mepivacaine in patients with irreversible pulpitis of mandibular molar.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Conventional inferior alveolar nerve block (IANB) is the most commonly used technique for
      achieving pulpal anesthesia in posterior mandibular endodontic procedures. However, IANB has
      a high failure rate and success rates are even lower when applied for the treatment of
      mandibular posterior teeth with irreversible pulpitis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>pulpal anesthesia</measure>
    <time_frame>Ten minutes after the inferior alveolar nerve block</time_frame>
    <safety_issue>No</safety_issue>
    <description>pulpal anesthesia was tested with an electric pulp stimulator</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>analgesia</measure>
    <time_frame>the patients were instructed to report any painful sensation at three phases: 1) dentin 2) pulp chamber 3) root canal</time_frame>
    <safety_issue>No</safety_issue>
    <description>To evaluate the intensity of pain during the pulpectomy a verbal analogic scale was adopted</description>
  </secondary_outcome>
  <other_outcome>
    <measure>lip anesthesia</measure>
    <time_frame>ten minutes after the inferior alveolar nerve block</time_frame>
    <safety_issue>No</safety_issue>
    <description>The investigators evaluated the subjective lip anethesia by asking the patient whether his/her lip was numb</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injections of 3.6 mL of 2% lidocaine with 1:100,000 epinephrine Intervention: inferior alveolar nerve block injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mepivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injections of 3.6 mL of 2% mepivacaine with 1:100,000 epinephrine Intervention: inferior alveolar nerve block injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>articaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injections of 3.6 mL of 4% articaine with 1:100,000 epinephrine Intervention: inferior alveolar nerve block injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intervention: inferior alveolar nerve block injection</intervention_name>
    <description>-22 patients received inferior alveolar nerve block injections of 3.6 mL (equivalent to 2 cartridges)</description>
    <arm_group_label>lidocaine</arm_group_label>
    <arm_group_label>mepivacaine</arm_group_label>
    <arm_group_label>articaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of irreversible pulpitis

          -  good health

          -  had at least 1 adjacent tooth plus a healthy canine

        Exclusion Criteria:

          -  took medication could be interacting with any of the anesthetics used
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabel P Tortamano, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>USão Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emergency Center of the School of Dentistry at the University of São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>05508-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>January 31, 2014</lastchanged_date>
  <firstreceived_date>September 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Isabel Peixoto Tortamano</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>articaine</keyword>
  <keyword>lidocaine</keyword>
  <keyword>mepivacaine</keyword>
  <keyword>inferior alveolar nerve block</keyword>
  <keyword>irreversible pulpitis</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Mepivacaine</mesh_term>
    <mesh_term>Carticaine</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
